Split dose iodine-123-IMP SPECT: sequential quantitative regional cerebral blood flow change with pharmacological intervention. 1994

K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
Department of Nuclear Medicine, Osaka University Medical School, Japan.

At least two quantitative rCBF measurements are needed to evaluate rCBF changes with pharmacological intervention. We have developed the split dose 123I-IMP SPECT method, which enables measurement of rCBF to be repeated in a short time. METHODS Thirty-one cerebrovascular disease patients were investigated to assess reproducibility and vasoreactivity to acetazolamide. During 44-min dynamic SPECT imaging, 123I-IMP injection and respective arterial sampling were performed twice at an interval of about 25 min. The rCBF values were calculated using a microsphere model in which the washout of 123I-IMP from the brain can be negligible in the first several minutes after injection. For the second rCBF measurement, the remaining activity due to the first 123I-IMP injection was estimated and subtracted from the total brain activity. RESULTS In ten patients, two consecutive resting mean rCBF values in the MCA territory (CBF1 and CBF2) had good correlation (CBF1 = 47.4 +/- 4.0 (ml/min/100 ml: mean +/- s.d.), CBF2 = 45.2 +/- 8.2, CBF2 = 0.900*CBF1 + 2.9, r = 0.915). In 11 patients with occlusive lesions in the unilateral ICA system, mean rCBF in the MCA territory was increased by only 27.7% +/- 14.0% in the affected side by a 1-g intravenous acetazolamide injection, while 44.5% +/- 12.3% increase was found in the nonaffected side. In 10 patients without a major arterial lesion, a 49.7% +/- 17.0% increase of rCBF was demonstrated. CONCLUSIONS This split dose method 123I-IMP SPECT can be useful to estimate vascular reserve.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086 Acetazolamide One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) Acetadiazol,Acetazolam,Acetazolamide Sodium, (Sterile),Acetazolamide, Monosodium Salt,Ak-Zol,Apo-Acetazolamide,Diacarb,Diamox,Diuramide,Défiltran,Edemox,Glauconox,Glaupax,Huma-Zolamide,Ak Zol,AkZol,Apo Acetazolamide,ApoAcetazolamide,Huma Zolamide,HumaZolamide
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.

Related Publications

K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
December 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
September 1989, The Japanese journal of psychiatry and neurology,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
April 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
December 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
February 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
July 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
October 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
October 1999, Annals of nuclear medicine,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
April 2002, Annals of nuclear medicine,
K Hashikawa, and M Matsumoto, and H Moriwaki, and N Oku, and Y Okazaki, and T Uehara, and N Handa, and H Kusuoka, and T Kamada, and T Nishimura
July 1991, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!